New Nordic Healthbrands AB (publ) årsredovisning 2020

New Nordics årsredovisning 2020 är nu tillgänglig på bolagets hemsida https://newnordic.se/se/investor/financial-reports.html

Årsredovisningen finns också tillgänglig på bolagets kontor i Malmö och sänds till aktieägare som så begär och uppger sin postadress genom att kontakta Ivan Ruscic på telefon 040-239520 eller via e-post till [email protected].

Med vänliga hälsningar

Karl Kristian Bergman Jensen, CEO

New Nordic Healthbrands AB
Södra Förstadsgatan 3 C
SE-211 43 Malmö
Sweden

Malmö 26 mars 2021

Kontakt:
Karl Kristian Bergman Jensen, CEO +46 40-239520.
Ivan Ruscic, CFO +46 40-239520.

New Nordic Healthbrands AB (publ), SE-211 43 Malmö, telefon +040-239520, email: [email protected]. Org. nr. 556698-0453.

Certified advisor: Mangold Fondkommission AB. +46 8 503 01 550, [email protected].

New Nordic Healthbrands AB (publ) grundades 1990 och är noterat på Nasdaq First North Growth Market Sweden sedan 2007. Företagets affärsidé är att erbjuda de mest effektiva och säkra kosttillskotten, naturliga läkemedel och kosmetiska produkter för specifika hälso- och skönhetsfrågor. New Nordics produkter finns nu tillgängliga i 40 länder i apotek, hälsobutiker, skönhetsbutiker og travel retail. New Nordic har sina egna mindre försäljnings- och marknadsföringsföretag i de flesta europeiska länder, Kanada och USA, för att organisera lokala marknadsföringskampanjer, betjäna återförsäljare och för att betjäna slutkunderna. År 2020 var försäljningen 450 MSEK. Nästan alla New Nordics produkter som säljs över hela världen tillverkas i Skandinavien. För mer information, besök www.newnordic.se.

New Nordic Healthbrands AB (publ) Six Month Report January - June 2021

FIRST HALF-YEAR 2021

  • Net sales amounted to MSEK 268.9 (217,0), an increase of 30.8 percent in local currencies and 23,9 percent in SEK.
  • Gross margin decreased to 68.0 percent (70.1).
  • EBITDA increased to MSEK 24.6 (11.8).
  • Operating profit increased to MSEK 24.1 (11.4).
  • Profit after tax for the period increased to MSEK 19.1 (8.7).
  • Earnings per share after tax increased to SEK 3.08 (1.40).



New Nordic Healthbrands AB (publ) Three Month Report January - March 2021

Q1 2021

  • Net sales amounted to MSEK 127,8 (112.3), an increase of 13.9 percent. In local currencies, the increase was 21.1 percent.
  • Gross margin decreased to 67.0 percent (71.6).
  • EBITDA increased to MSEK 13.4 (7.1).
  • Operating profit increased to MSEK 13.2 (6.9).
  • Profit after tax for the period increased to MSEK 10.4 (5.4).
  • Earnings per share after tax increased to SEK 1.68 (0.87).


Kallelse till Årstämma i New Nordic Healthbrands AB (publ)

Aktieägarna i New Nordic Healthbrands AB (publ) kallas härmed till årsstämma.

Plats: Quality Hotel View
Adress: Hyllie Stationstorg 29, 215 32 Malmö
Tid: Torsdagen den 29 april 2021 kl. 10.00 orsdagen den 28 april 2016 kl 10.00.


New Nordic Healthbrands AB has decided to postpone the application for listing on Nasdaq Main Market Stockholm due to the Covid-19 pandemic. The new plan for listing is in 2022.

Following our announcement on February 28, 2020, we confirm that we are preparing for listing on Nasdaq Main Market Stockholm.

However, we have decided to postpone the application until the Covid-19 pandemic has eased.


New Nordic Healthbrands AB (publ) Full Year Report January - December 2020

FULL YEAR 2020

  • Net sales amounted to MSEK 450,1 (452,6), a decrease of 0.6 percent. In local currencies, there was an increase of 2.1 percent.
  • Gross margin decreased to 68.7 percent (69.7).
  • EBITDA decreased to MSEK 25.7 (36.9).
  • Operating profit decreased to MSEK 24.9 (36.3).
  • Profit after tax for the period decreased to MSEK 17.8 (28.1).
  • Earnings per share after tax decreased to SEK 2.87 (4.53).

Q4 2020

  • Net sales amounted to MSEK 117.8 (114.4), an increase of 3.0 percent. In local currencies, the increase was 8.4 percent.
  • Gross margin decreased to 67.1 percent (67.7).
  • EBITDA decreased to MSEK 5.7 (7.1).
  • Operating profit decreased to MSEK 5.5 (7.0).
  • Profit after tax for the period decreased to MSEK 2.7 (4.6).
  • Earnings per share decreased to SEK 0.43 (0.75).

New Nordic Healthbrands AB (publ) Three Month Report January - September 2020

NINE MONTHS 2020

  • Net sales amounted to MSEK 332.3 (338.2), an decrease of 1.8 percent. In local currencies, the decrease was 0.1 percent.
  • Gross margin decreased to 69.3 percent (70.4).
  • EBITDA decreased to MSEK 20.007 (29.8).
  • Operating profit decreased to MSEK 19.4 (29.3).
  • Profit after tax for the period increased to MSEK 15.1 (23.4).
  • Earnings per share after tax increased to SEK 3.23 (4.81).

Six Month Report January - June 2020

SIX MONTHS 2020

  • Net sales amounted to MSEK 217.0 (220.2), a decrease of 1.4 percent. In local currencies, the decrease was 1.2 percent.
  • Gross margin decreased to 70.1 percent (70.3).
  • EBITDA decreased to MSEK 11.8 (15.3).
  • Operating profit decreased to MSEK 11.4 (15.0).
  • Profit after tax for the period decreased to MSEK 8.6 (12.0).Earnings per share after tax decreased to SEK 1.40 (1.94).

Q2 2020

  • Net sales amounted to MSEK 104.8 (116.5), a decrease of 10.1 percent. In local currencies, the decrease was 9.9 percent.
  • Gross margin decreased to 68.5 percent (71.0).
  • EBITDA decreased to MSEK 4.8 (6.8).
  • Operating profit decreased to MSEK 4.5 (6.6).
  • Profit after tax for the period decreased to MSEK 3.3 (5.3).
  • Earnings per share after tax decreased to SEK 0.53 (0.85).

Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Nybrogatan 34
Box 5216
102 45 Stockholm

08-692 21 90

Om beQuoted